CORSINI, ALBERTO
CORSINI, ALBERTO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
2025 A. Gallo, W. Le Goff, R.D. Santos, I. Fichtner, S. Carugo, A. Corsini, C. Sirtori, M. Ruscica
2024 consensus document of the Italian Society of Arterial Hypertension (SIIA) and the Italian Society of Cardiovascular Prevention (SIPREC): update on LDL cholesterol lowering in patients with arterial hypertension
2025 M.L. Muiesan, A. Virdis, G. Tocci, C. Borghi, A.F.G. Cicero, C. Ferri, M. Pirro, A. Corsini, M. Volpe
Farmacologia clinica delle terapie di associazione nella prevenzione e nel trattamento delle malattie cardiovascolari
2025 N. Ferri, A. Corsini
SIMVASTATIN AMELIORATES SENESCENCE-INDUCED MITOCHONDRIAL DYSFUNCTION IN VASCULAR SMOOTH MUSCLE CELLS
2025 C. Rossi, C. Macchi, C. D'Alonzo, M. Venturin, M. Ruscica, A. Corsini, C. Battaglia, S. Bellosta
Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity
2024 C. Macchi, A. Giachi, I. Fichtner, S. Pedretti, P.S. Puttini, N. Mitro, A. Corsini, M. Ruscica, R. Gualtierotti
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
2024 L. Barbieri, G. Tumminello, I. Fichtner, A. Corsini, R.D. Santos, S. Carugo, M. Ruscica
Vescicole extracellulari nel contesto dell'aterosclerosi = Extracellular vesicles in atherothrombosis
2024 M. Ruscica, A. Rizzuto, C. Macchi, I. Fichtner, S. Carugo, A. Corsini
Impact of cigarette smoke on vascular smooth muscle cell senescence
2024 C. Rossi, M. Venturin, C. Battaglia, A. Corsini, S. Bellosta
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study
2024 M. Ruscica, C. Macchi, S. Gandini, D. Macis, A. Guerrieri-Gonzaga, V. Aristarco, D. Serrano, M. Lazzeroni, A.S. Rizzuto, A. Gaeta, A. Corsini, M. Gulisano, H. Johansson, B. Bonanni
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
2024 I. Fichtner, C. Macchi, A.S. Rizzuto, S. Carugo, A. Corsini, M. Ruscica
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
2024 S. Bellosta, A. Corsini
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
2024 N. Ferri, M. Ruscica, S. Fazio, A. Corsini
Lipid-lowering approaches to manage statin-intolerant patients
2024 M. Ruscica, A. Bertoletti, C. Gobbi, C.R. Sirtori, S. Carugo, A. Corsini
Fixed Combination for the Treatment of Dyslipidaemia
2023 N. Ferri, M. Ruscica, R.D. Santos, A. Corsini
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
2023 E. Raschi, M. Casula, A.F.G. Cicero, A. Corsini, C. Borghi, A. Catapano
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
2023 S. Carugo, C.R. Sirtori, G. Gelpi, A. Corsini, L. Tokgozoglu, M. Ruscica
Characterization of replicative and doxorubicin-induced senescence models in vascular smooth muscle cells
2023 C. Rossi, M. Venturin, C. Macchi, M. Ruscica, A. Corsini, C. Battaglia, S. Bellosta
Pollution from fine particulate matter and atherosclerosis: A narrative review
2023 C. Macchi, C.R. Sirtori, A. Corsini, P. Mannuccio Mannucci, M. Ruscica
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
2023 M. Ruscica, C. Macchi, A. Giuliani, A.S. Rizzuto, D. Ramini, M. Sbriscia, S. Carugo, A.R. Bonfigli, A. Corsini, F. Olivieri, J. Sabbatinelli
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms
2023 L. Lazzarato, L. Bianchi, A. Andolfo, A. Granata, M. Lombardi, M. Sinelli, B. Rolando, M. Carini, A. Corsini, R. Fruttero, L. Arnaboldi